The importance of dendritic cells in maintaining immune tolerance

Journal of Immunology

Volumn 198, Issue 6, 2017, Pages 2223-2231

  Audiger, Cindy ^a,b   Rahman, M Jubayer ^c   Yun, Tae Jin ^d,e   Tarbell, Kristin V ^c   Lesage, Sylvie ^a,b  

^a MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^d CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD70 ANTIGEN;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; DENDRITIC CELL; ENVIRONMENTAL FACTOR; GENETIC VARIABILITY; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; LYMPHOCYTE ACTIVATION; NONHUMAN; REGULATORY T LYMPHOCYTE; REVIEW; STEADY STATE; THYMUS; ANIMAL; ANTIGEN PRESENTATION; IMMUNOLOGY; IMMUNOTHERAPY; PROCEDURES; T LYMPHOCYTE; TRENDS;

ANIMALS; ANTIGEN PRESENTATION; AUTOIMMUNE DISEASES; AUTOIMMUNITY; DENDRITIC CELLS; HUMANS; IMMUNE TOLERANCE; IMMUNOTHERAPY; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES;

EID: 85014594261     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1601629     Document Type: Review

References (166)

1. Steinman, R. M. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9: 271-296.
2. Salem, S., D. Langlais, F. Lefebvre, G. Bourque, V. Bigley, M. Haniffa, J. L. Casanova, D. Burk, A. Berghuis, K. M. Butler, et al. 2014. Functional characterization of the human dendritic cell immunodeficiency associated with the IRF8K108E mutation. Blood 124: 1894-1904.
3. Birnberg, T., L. Bar-On, A. Sapoznikov, M. L. Caton, L. Cervantes-Barragán, D. Makia, R. Krauthgamer, O. Brenner, B. Ludewig, D. Brockschnieder, et al. 2008. Lack of conventional dendritic cells is compatible with normal development and T cell homeostasis, but causes myeloid proliferative syndrome. Immunity 29: 986-997.
4. Ohnmacht, C., A. Pullner, S. B. King, I. Drexler, S. Meier, T. Brocker, and D. Voehringer. 2009. Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity. J. Exp. Med. 206: 549-559.
5. Singh, R. P., S. Hasan, S. Sharma, S. Nagra, D. T. Yamaguchi, D. T. Wong, B. H. Hahn, and A. Hossain. 2014. Th17 cells in inflammation and autoimmunity. Autoimmun. Rev. 13: 1174-1181.
6. Satpathy, A. T., W. Kc, J. C. Albring, B. T. Edelson, N. M. Kretzer, D. Bhattacharya, T. L. Murphy, and K. M. Murphy. 2012. Zbtb46 expression distinguishes classical dendritic cells and their committed progenitors from other immune lineages. J. Exp. Med. 209: 1135-1152.
7. Meredith, M. M., K. Liu, G. Darrasse-Jeze, A. O. Kamphorst, H. A. Schreiber, P. Guermonprez, J. Idoyaga, C. Cheong, K. H. Yao, R. E. Niec, and M. C. Nussenzweig. 2012. Expression of the zinc finger transcription factor zDC (Zbtb46, Btbd4) defines the classical dendritic cell lineage. J. Exp. Med. 209: 1153-1165.
8. Loschko, J., H. A. Schreiber, G. J. Rieke, D. Esterházy, M. M. Meredith, V. A. Pedicord, K. H. Yao, S. Caballero, E. G. Pamer, D. Mucida, and M. C. Nussenzweig. 2016. Absence of MHC class II on cDCs results in microbialdependent intestinal inflammation. J. Exp. Med. 213: 517-534.
9. O'Keeffe, M., T. C. Brodnicki, B. Fancke, D. Vremec, G. Morahan, E. Maraskovsky, R. Steptoe, L. C. Harrison, and K. Shortman. 2005. Fms-like tyrosine kinase 3 ligand administration overcomes a genetically determined dendritic cell deficiency in NOD mice and protects against diabetes development. Int. Immunol. 17: 307-314.
10. Chen, M., Y. H. Wang, Y. Wang, L. Huang, H. Sandoval, Y. J. Liu, and J. Wang. 2006. Dendritic cell apoptosis in the maintenance of immune tolerance. Science 311: 1160-1164.
11. Chen, M., L. Huang, and J. Wang. 2007. Deficiency of Bim in dendritic cells contributes to overactivation of lymphocytes and autoimmunity. Blood 109: 4360-4367.
12. García-González, P., G. Ubilla-Olguín, D. Catalán, K. Schinnerling, and J. C. Aguillón. 2016. Tolerogenic dendritic cells for reprogramming of lymphocyte responses in autoimmune diseases. Autoimmun. Rev. 15: 1071-1080.
13. Liu, J., and X. Cao. 2015. Regulatory dendritic cells in autoimmunity: A comprehensive review. J. Autoimmun. 63: 1-12.
14. Zanoni, I., and F. Granucci. 2011. The regulatory role of dendritic cells in the induction and maintenance of T-cell tolerance. Autoimmunity 44: 23-32.
15. Wakkach, A., N. Fournier, V. Brun, J. P. Breittmayer, F. Cottrez, and H. Groux. 2003. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 18: 605-617.
16. Svensson, M., A. Maroof, M. Ato, and P. M. Kaye. 2004. Stromal cells direct local differentiation of regulatory dendritic cells. Immunity 21: 805-816.
17. Zhang, M., H. Tang, Z. Guo, H. An, X. Zhu, W. Song, J. Guo, X. Huang, T. Chen, J. Wang, and X. Cao. 2004. Splenic stroma drives mature dendritic cells to differentiate into regulatory dendritic cells. Nat. Immunol. 5: 1124-1133.
18. Hogquist, K. A., T. A. Baldwin, and S. C. Jameson. 2005. Central tolerance: learning self-control in the thymus. Nat. Rev. Immunol. 5: 772-782.
19. Labrecque, N., T. Baldwin, and S. Lesage. 2011. Molecular and genetic parameters defining T-cell clonal selection. Immunol. Cell Biol. 89: 16-26.
20. Klein, L., B. Kyewski, P. M. Allen, and K. A. Hogquist. 2014. Positive and negative selection of the T cell repertoire: what thymocytes see (and don't see). Nat. Rev. Immunol. 14: 377-391.
21. Baldwin, T. A., K. A. Hogquist, and S. C. Jameson. 2004. The fourth way? Harnessing aggressive tendencies in the thymus. J. Immunol. 173: 6515-6520.
22. Pobezinsky, L. A., G. S. Angelov, X. Tai, S. Jeurling, F. Van Laethem, L. Feigenbaum, J. H. Park, and A. Singer. 2012. Clonal deletion and the fate of autoreactive thymocytes that survive negative selection. Nat. Immunol. 13: 569-578.
23. Jenkinson, E. J., G. Anderson, and J. J. Owen. 1992. Studies on T cell maturation on defined thymic stromal cell populations in vitro. J. Exp. Med. 176: 845-853.
24. Gallegos, A. M., and M. J. Bevan. 2004. Central tolerance to tissue-specific antigens mediated by direct and indirect antigen presentation. J. Exp. Med. 200: 1039-1049.
25. Guerri, L., I. Peguillet, Y. Geraldo, S. Nabti, V. Premel, and O. Lantz. 2013. Analysis of APC types involved in CD4 tolerance and regulatory T cell generation using reaggregated thymic organ cultures. J. Immunol. 190: 2102-2110.
26. van Meerwijk, J. P., S. Marguerat, R. K. Lees, R. N. Germain, B. J. Fowlkes, and H. R. MacDonald. 1997. Quantitative impact of thymic clonal deletion on the T cell repertoire. J. Exp. Med. 185: 377-383.
27. Brocker, T., M. Riedinger, and K. Karjalainen. 1997. Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo. J. Exp. Med. 185: 541-550.
28. Hu, Z., J. N. Lancaster, C. Sasiponganan, and L. I. Ehrlich. 2015. CCR4 promotes medullary entry and thymocyte-dendritic cell interactions required for central tolerance. J. Exp. Med. 212: 1947-1965.
29. Vremec, D., J. Pooley, H. Hochrein, L. Wu, and K. Shortman. 2000. CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. J. Immunol. 164: 2978-2986.
30. Lahoud, M. H., A. I. Proietto, K. H. Gartlan, S. Kitsoulis, J. Curtis, J. Wettenhall, M. Sofi, C. Daunt, M. O'keeffe, I. Caminschi, et al. 2006. Signal regulatory protein molecules are differentially expressed by CD82 dendritic cells. J. Immunol. 177: 372-382.
31. Corcoran, L., I. Ferrero, D. Vremec, K. Lucas, J. Waithman, M. O'Keeffe, L. Wu, A. Wilson, and K. Shortman. 2003. The lymphoid past of mouse plasmacytoid cells and thymic dendritic cells. J. Immunol. 170: 4926-4932.
32. Wu, L., and K. Shortman. 2005. Heterogeneity of thymic dendritic cells. Semin. Immunol. 17: 304-312.
33. Porritt, H. E., K. Gordon, and H. T. Petrie. 2003. Kinetics of steady-state differentiation and mapping of intrathymic-signaling environments by stem cell transplantation in nonirradiated mice. J. Exp. Med. 198: 957-962.
34. Donskoy, E., and I. Goldschneider. 2003. Two developmentally distinct populations of dendritic cells inhabit the adult mouse thymus: demonstration by differential importation of hematogenous precursors under steady state conditions. J. Immunol. 170: 3514-3521.
35. Atibalentja, D. F., K.M. Murphy, and E. R. Unanue. 2011. Functional redundancy between thymic CD8a+ and Sirpa+ conventional dendritic cells in presentation of blood-derived lysozyme by MHC class II proteins. J. Immunol. 186: 1421-1431.
36. Hubert, F. X., S. A. Kinkel, G. M. Davey, B. Phipson, S. N. Mueller, A. Liston, A. I. Proietto, P. Z. Cannon, S. Forehan, G. K. Smyth, et al. 2011. Aire regulates the transfer of antigen from mTECs to dendritic cells for induction of thymic tolerance. Blood 118: 2462-2472.
37. Ardouin, L., H. Luche, R. Chelbi, S. Carpentier, A. Shawket, F. Montanana Sanchis, C. Santa Maria, P. Grenot, Y. Alexandre, C. Grégoire, et al. 2016. Broad and largely concordant molecular changes characterize tolerogenic and immunogenic dendritic cell maturation in thymus and periphery. Immunity 45: 305-318.
38. Bonasio, R., M. L. Scimone, P. Schaerli, N. Grabie, A. H. Lichtman, and U. H. von Andrian. 2006. Clonal deletion of thymocytes by circulating dendritic cells homing to the thymus. Nat. Immunol. 7: 1092-1100.
39. Baba, T., Y. Nakamoto, and N. Mukaida. 2009. Crucial contribution of thymic Sirpa+ conventional dendritic cells to central tolerance against blood-borne antigens in a CCR2-dependent manner. J. Immunol. 183: 3053-3063.
40. Kroger, C. J., N. A. Spidale, B. Wang, and R. Tisch. 2017. Thymic dendritic cell subsets display distinct efficiencies and mechanisms of intercellular MHC transfer. J. Immunol. 198: 249-256.
41. Proietto, A. I., S. van Dommelen, P. Zhou, A. Rizzitelli, A. D'Amico, R. J. Steptoe, S. H. Naik, M. H. Lahoud, Y. Liu, P. Zheng, et al. 2008. Dendritic cells in the thymus contribute to T-regulatory cell induction. [Published erratum appears in 2009 Proc. Natl. Acad. Sci. USA 106: 1679.] Proc. Natl. Acad. Sci. USA 105: 19869-19874.
42. Coquet, J. M., J. C. Ribot, N. Babała, S. Middendorp, G. van der Horst, Y. Xiao, J. F. Neves, D. Fonseca-Pereira, H. Jacobs, D. J. Pennington, et al. 2013. Epithelial and dendritic cells in the thymic medulla promote CD4+Foxp3+ regulatory T cell development via the CD27-CD70 pathway. J. Exp. Med. 210: 715-728.
43. Liston, A., K.M. Nutsch, A. G. Farr, J. M. Lund, J. P. Rasmussen, P. A. Koni, and A. Y. Rudensky. 2008. Differentiation of regulatory Foxp3+ T cells in the thymic cortex. Proc. Natl. Acad. Sci. USA 105: 11903-11908.
44. Hawiger, D., K. Inaba, Y. Dorsett, M. Guo, K. Mahnke, M. Rivera, J. V. Ravetch, R. M. Steinman, and M. C. Nussenzweig. 2001. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194: 769-779.
45. Skokos, D., G. Shakhar, R. Varma, J. C. Waite, T. O. Cameron, R. L. Lindquist, T. Schwickert, M. C. Nussenzweig, and M. L. Dustin. 2007. Peptide-MHC potency governs dynamic interactions between T cells and dendritic cells in lymph nodes. Nat. Immunol. 8: 835-844.
46. Hughes, P. D., G. T. Belz, K. A. Fortner, R. C. Budd, A. Strasser, and P. Bouillet. 2008. Apoptosis regulators Fas and Bim cooperate in shutdown of chronic immune responses and prevention of autoimmunity. Immunity 28: 197-205.
47. Hutcheson, J., J. C. Scatizzi, A. M. Siddiqui, G. K. Haines, III, T. Wu, Q. Z. Li L. S. Davis, C. Mohan, and H. Perlman. 2008. Combined deficiency of proapoptotic regulators Bim and Fas results in the early onset of systemic autoimmunity. Immunity 28: 206-217.
48. Oh, J., S. H. Kim, S. Ahn, and C. E. Lee. 2012. Suppressors of cytokine signaling promote Fas-induced apoptosis through downregulation of NF-kB and mitochondrial Bfl-1 in leukemic T cells. J. Immunol. 189: 5561-5571.
49. Wallet, M. A., P. Sen, and R. Tisch. 2005. Immunoregulation of dendritic cells. Clin. Med. Res. 3: 166-175.
50. George, T. C., J. Bilsborough, J. L. Viney, and A. M. Norment. 2003. High antigen dose and activated dendritic cells enable Th cells to escape regulatory T cell-mediated suppression in vitro. Eur. J. Immunol. 33: 502-511.
51. Steinman, R. M. 2012. Decisions about dendritic cells: past, present, and future. Annu. Rev. Immunol. 30: 1-22.
52. Alvarez, D., E. H. Vollmann, and U. H. von Andrian. 2008. Mechanisms and consequences of dendritic cell migration. Immunity 29: 325-342.
53. Randolph, G. J., V. Angeli, and M. A. Swartz. 2005. Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nat. Rev. Immunol. 5: 617-628.
54. Dong, H., and T. N. Bullock. 2014. Metabolic influences that regulate dendritic cell function in tumors. Front. Immunol. 5: 24.
55. Caux, C., C. Massacrier, B. Vanbervliet, B. Dubois, C. Van Kooten, I. Durand, and J. Banchereau. 1994. Activation of human dendritic cells through CD40 crosslinking. J. Exp. Med. 180: 1263-1272.
56. Tan, J. K., and H. C. O'Neill. 2005. Maturation requirements for dendritic cells in T cell stimulation leading to tolerance versus immunity. J. Leukoc. Biol. 78: 319-324.
57. Jensen, S. S., and M. Gad. 2010. Differential induction of inflammatory cytokines by dendritic cells treated with novel TLR-agonist and cytokine based cocktails: targeting dendritic cells in autoimmunity. J. Inflamm. (Lond.) 7: 37.
58. Salomon, B., D. J. Lenschow, L. Rhee, N. Ashourian, B. Singh, A. Sharpe, and J. A. Bluestone. 2000. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12: 431-440.
59. Zheng, Y., C. N. Manzotti, M. Liu, F. Burke, K. I. Mead, and D. M. Sansom. 2004. CD86 and CD80 differentially modulate the suppressive function of human regulatory T cells. J. Immunol. 172: 2778-2784.
60. Yamazaki, S., T. Iyoda, K. Tarbell, K. Olson, K. Velinzon, K. Inaba, and R. M. Steinman. 2003. Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells. J. Exp. Med. 198: 235-247.
61. Johnson, D. J., and P. S. Ohashi. 2013. Molecular programming of steady-state dendritic cells: impact on autoimmunity and tumor immune surveillance. Ann. N. Y. Acad. Sci. 1284: 46-51.
62. Gon, Y., Y. Asai, S. Hashimoto, K. Mizumura, I. Jibiki, T. Machino, C. Ra, and T. Horie. 2004. A20 inhibits Toll-like receptor 2-and 4-mediated interleukin-8 synthesis in airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 31: 330-336.
63. Hammer, G. E., E. E. Turer, K. E. Taylor, C. J. Fang, R. Advincula, S. Oshima, J. Barrera, E. J. Huang, B. Hou, B. A. Malynn, et al. 2011. Expression of A20 by dendritic cells preserves immune homeostasis and prevents colitis and spondyloarthritis. Nat. Immunol. 12: 1184-1193.
64. Kool, M., G. van Loo, W. Waelput, S. De Prijck, F. Muskens, M. Sze, J. van Praet, F. Branco-Madeira, S. Janssens, B. Reizis, et al. 2011. The ubiquitin-editing protein A20 prevents dendritic cell activation, recognition of apoptotic cells, and systemic autoimmunity. Immunity 35: 82-96.
65. Mayer, C. T., L. Berod, and T. Sparwasser. 2012. Layers of dendritic cell-mediated T cell tolerance, their regulation and the prevention of autoimmunity. Front. Immunol. 3: 183.
66. Lee, G. K., H. J. Park, M. Macleod, P. Chandler, D. H. Munn, and A. L. Mellor. 2002. Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division. Immunology 107: 452-460.
67. Mellor, A. L., and D. H. Munn. 2004. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat. Rev. Immunol. 4: 762-774.
68. Probst, H. C., S. Muth, and H. Schild. 2014. Regulation of the tolerogenic function of steady-state DCs. Eur. J. Immunol. 44: 927-933.
69. Yamazaki, T., H. Akiba, H. Iwai, H. Matsuda, M. Aoki, Y. Tanno, T. Shin, H. Tsuchiya, D. M. Pardoll, K. Okumura, et al. 2002. Expression of programmed death 1 ligands by murine T cells and APC. J. Immunol. 169: 5538-5545.
70. Probst, H. C., K. McCoy, T. Okazaki, T. Honjo, and M. van den Broek. 2005. Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4. Nat. Immunol. 6: 280-286.
71. Steinman, R. M., and J. Idoyaga. 2010. Features of the dendritic cell lineage. Immunol. Rev. 234: 5-17.
72. Miller, J. C., B. D. Brown, T. Shay, E. L. Gautier, V. Jojic, A. Cohain, G. Pandey, M. Leboeuf, K. G. Elpek, J. Helft, et al. 2012. Deciphering the transcriptional network of the dendritic cell lineage. Nat. Immunol. 13: 888-899.
73. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
74. Tarbell, K. V., S. Yamazaki, K. Olson, P. Toy, and R. M. Steinman. 2004. CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J. Exp. Med. 199: 1467-1477.
75. Price, J. D., and K. V. Tarbell. 2015. The role of dendritic cell subsets and innate immunity in the pathogenesis of type 1 diabetes and other autoimmune diseases. Front. Immunol. 6: 288.
76. Bates, E. E., N. Fournier, E. Garcia, J. Valladeau, I. Durand, J. J. Pin, S. M. Zurawski, S. Patel, J. S. Abrams, S. Lebecque, et al. 1999. APCs express DCIR, a novel C-type lectin surface receptor containing an immunoreceptor tyrosine-based inhibitory motif. J. Immunol. 163: 1973-1983.
77. Meyer-Wentrup, F., D. Benitez-Ribas, P. J. Tacken, C. J. Punt, C. G. Figdor, I. J. de Vries, and G. J. Adema. 2008. Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-A production. Blood 111: 4245-4253.
78. Price, J. D., C. Hotta-Iwamura, Y. Zhao, N. M. Beauchamp, and K. V. Tarbell. 2015. DCIR2+ cDC2 DCs and Zbtb32 restore CD4+ T-Cell tolerance and inhibit diabetes. Diabetes 64: 3521-3531.
79. Dudziak, D., A. O. Kamphorst, G. F. Heidkamp, V. R. Buchholz, C. Trumpfheller, S. Yamazaki, C. Cheong, K. Liu, H. W. Lee, C. G. Park, et al. 2007. Differential antigen processing by dendritic cell subsets in vivo. Science 315: 107-111.
80. Calabro, S., D. Liu, A. Gallman, M. S. Nascimento, Z. Yu, T. T. Zhang, P. Chen, B. Zhang, L. Xu, U. Gowthaman, et al. 2016. Differential intrasplenic migration of dendritic cell subsets tailors adaptive immunity. Cell Rep. 16: 2472-2485.
81. Lindquist, R. L., G. Shakhar, D. Dudziak, H. Wardemann, T. Eisenreich, M. L. Dustin, and M. C. Nussenzweig. 2004. Visualizing dendritic cell networks in vivo. Nat. Immunol. 5: 1243-1250.
82. Witmer-Pack, M. D., W. J. Swiggard, A. Mirza, K. Inaba, and R. M. Steinman. 1995. Tissue distribution of the DEC-205 protein that is detected by the monoclonal antibody NLDC-145. II. Expression in situ in lymphoid and nonlymphoid tissues. Cell. Immunol. 163: 157-162.
83. Mahnke, K., M. Guo, S. Lee, H. Sepulveda, S. L. Swain, M. Nussenzweig, and R. M. Steinman. 2000. The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments. J. Cell Biol. 151: 673-684.
84. Iyoda, T., S. Shimoyama, K. Liu, Y. Omatsu, Y. Akiyama, Y. Maeda, K. Takahara, R. M. Steinman, and K. Inaba. 2002. The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J. Exp. Med. 195: 1289-1302.
85. Lahoud, M. H., F. Ahmet, J. G. Zhang, S. Meuter, A. N. Policheni, S. Kitsoulis, C. N. Lee, M. O'Keeffe, L. C. Sullivan, A. G. Brooks, et al. 2012. DEC-205 is a cell surface receptor for CpG oligonucleotides. Proc. Natl. Acad. Sci. USA 109: 16270-16275.
86. Sancho, D., and C. Reis e Sousa. 2012. Signaling by myeloid C-type lectin receptors in immunity and homeostasis. Annu. Rev. Immunol. 30: 491-529.
87. Li, D., G. Romain, A. L. Flamar, D. Duluc, M. Dullaers, X. H. Li, S. Zurawski, N. Bosquet, A. K. Palucka, R. Le Grand, et al. 2012. Targeting self-and foreign antigens to dendritic cells via DC-ASGPR generates IL-10-producing suppressive CD4+ T cells. J. Exp. Med. 209: 109-121.
88. Uto, T., T. Fukaya, H. Takagi, K. Arimura, T. Nakamura, N. Kojima, B. Malissen, and K. Sato. 2016. Clec4A4 is a regulatory receptor for dendritic cells that impairs inflammation and T-cell immunity. Nat. Commun. 7: 11273.
89. Jones, A., J. Bourque, L. Kuehm, A. Opejin, R. M. Teague, C. Gross, and D. Hawiger. 2016. Immunomodulatory functions of BTLA and HVEM govern induction of extrathymic regulatory T cells and tolerance by dendritic cells. Immunity 45: 1066-1077.
90. Yamazaki, S., D. Dudziak, G. F. Heidkamp, C. Fiorese, A. J. Bonito, K. Inaba, M. C. Nussenzweig, and R. M. Steinman. 2008. CD8+ CD205+ splenic dendritic cells are specialized to induce Foxp3+ regulatory T cells. J. Immunol. 181: 6923-6933.
91. Schildknecht, A., S. Brauer, C. Brenner, K. Lahl, H. Schild, T. Sparwasser, H. C. Probst, and M. van den Broek. 2010. FoxP3+ regulatory T cells essentially contribute to peripheral CD8+ T-cell tolerance induced by steady-state dendritic cells. Proc. Natl. Acad. Sci. USA 107: 199-203.
92. Darrasse-Jèze, G., S. Deroubaix, H. Mouquet, G. D. Victora, T. Eisenreich, K. H. Yao, R. F. Masilamani, M. L. Dustin, A. Rudensky, K. Liu, and M. C. Nussenzweig. 2009. Feedback control of regulatory T cell homeostasis by dendritic cells in vivo. J. Exp. Med. 206: 1853-1862.
93. Kohli, K., A. Janssen, and R. Förster. 2016. Plasmacytoid dendritic cells induce tolerance predominantly by cargoing antigen to lymph nodes. Eur. J. Immunol. 46: 2659-2668.
94. Gehrie, E., W. Van der Touw, J. S. Bromberg, and J. C. Ochando. 2011. Plasmacytoid dendritic cells in tolerance. Methods Mol. Biol. 677: 127-147.
95. LeibundGut-Landmann, S., J. M. Waldburger, M. Krawczyk, L. A. Otten, T. Suter, A. Fontana, H. Acha-Orbea, and W. Reith. 2004. Mini-review: specificity and expression of CIITA, the master regulator of MHC class II genes. Eur. J. Immunol. 34: 1513-1525.
96. LeibundGut-Landmann, S., J. M. Waldburger, C. Reis e Sousa, H. Acha-Orbea, and W. Reith. 2004. MHC class II expression is differentially regulated in plasmacytoid and conventional dendritic cells. Nat. Immunol. 5: 899-908.
97. Irla, M., N. Kupfer, T. Suter, R. Lissilaa, M. Benkhoucha, J. Skupsky, P. H. Lalive, A. Fontana, W. Reith, and S. Hugues. 2010. MHC class II-restricted antigen presentation by plasmacytoid dendritic cells inhibits T cell-mediated autoimmunity. J. Exp. Med. 207: 1891-1905.
98. Martín, P., G. M. Del Hoyo, F. Anjuère, C. F. Arias, H. H. Vargas, A. Fernández-L, V. Parrillas, and C. Ardavín. 2002. Characterization of a new subpopulation of mouse CD8a+ B220+ dendritic cells endowed with type 1 interferon production capacity and tolerogenic potential. Blood 100: 383-390.
99. Manches, O., D. Munn, A. Fallahi, J. Lifson, L. Chaperot, J. Plumas, and N. Bhardwaj. 2008. HIV-activated human plasmacytoid DCs induce Tregs through an indoleamine 2,3-dioxygenase-dependent mechanism. J. Clin. Invest. 118: 3431-3439.
100. Wang, L., K. Pino-Lagos, V. C. de Vries, I. Guleria, M. H. Sayegh, and R. J. Noelle. 2008. Programmed death 1 ligand signaling regulates the generation of adaptive Foxp3+CD4+ regulatory T cells. Proc. Natl. Acad. Sci. USA 105: 9331-9336.
101. Hadeiba, H., T. Sato, A. Habtezion, C. Oderup, J. Pan, and E. C. Butcher. 2008. CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease. Nat. Immunol. 9: 1253-1260.
102. Jongbloed, S. L., R. A. Benson, M. B. Nickdel, P. Garside, I. B. McInnes, and J. M. Brewer. 2009. Plasmacytoid dendritic cells regulate breach of self-tolerance in autoimmune arthritis. J. Immunol. 182: 963-968.
103. Dubois, B., G. Joubert, M. Gomez de Aguero, M. Gouanvic, A. Goubier, and D. Kaiserlian. 2009. Sequential role of plasmacytoid dendritic cells and regulatory T cells in oral tolerance. Gastroenterology 137: 1019-1028.
104. Vitali, C., F. Mingozzi, A. Broggi, S. Barresi, F. Zolezzi, J. Bayry, G. Raimondi, I. Zanoni, and F. Granucci. 2012. Migratory, and not lymphoid-resident, dendritic cells maintain peripheral self-tolerance and prevent autoimmunity via induction of iTreg cells. Blood 120: 1237-1245.
105. Bennett, C. L., E. van Rijn, S. Jung, K. Inaba, R. M. Steinman, M. L. Kapsenberg, and B. E. Clausen. 2005. Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J. Cell Biol. 169: 569-576.
106. Idoyaga, J., C. Fiorese, L. Zbytnuik, A. Lubkin, J. Miller, B. Malissen, D. Mucida, M. Merad, and R. M. Steinman. 2013. Specialized role of migratory dendritic cells in peripheral tolerance induction. J. Clin. Invest. 123: 844-854.
107. Anandasabapathy, N., R. Feder, S. Mollah, S. W. Tse, M. P. Longhi, S. Mehandru, I. Matos, C. Cheong, D. Ruane, L. Brane, et al. 2014. Classical Flt3L-dependent dendritic cells control immunity to protein vaccine. J. Exp. Med. 211: 1875-1891.
108. Guilliams, M., K. Crozat, S. Henri, S. Tamoutounour, P. Grenot, E. Devilard, B. de Bovis, L. Alexopoulou, M. Dalod, and B. Malissen. 2010. Skin-draining lymph nodes contain dermis-derived CD1032 dendritic cells that constitutively produce retinoic acid and induce Foxp3+ regulatory T cells. Blood 115: 1958-1968.
109. Sun, C. M., J. A. Hall, R. B. Blank, N. Bouladoux, M. Oukka, J. R. Mora, and Y. Belkaid. 2007. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 204: 1775-1785.
110. Matteoli, G., E. Mazzini, I. D. Iliev, E. Mileti, F. Fallarino, P. Puccetti, M. Chieppa, and M. Rescigno. 2010. Gut CD103+ dendritic cells express indoleamine 2,3-dioxygenase which influences T regulatory/T effector cell balance and oral tolerance induction. Gut 59: 595-604.
111. Muzaki, A. R., P. Tetlak, J. Sheng, S. C. Loh, Y. A. Setiagani, M. Poidinger, F. Zolezzi, K. Karjalainen, and C. Ruedl. 2016. Intestinal CD103+CD11b2 dendritic cells restrain colitis via IFN-g-induced anti-inflammatory response in epithelial cells. Mucosal Immunol. 9: 336-351.
112. Janelsins, B. M., M. Lu, and S. K. Datta. 2014. Altered inactivation of commensal LPS due to acyloxyacyl hydrolase deficiency in colonic dendritic cells impairs mucosal Th17 immunity. Proc. Natl. Acad. Sci. USA 111: 373-378.
113. Steimle, A., and J. S. Frick. 2016. Molecular mechanisms of induction of tolerant and tolerogenic intestinal dendritic cells in mice. J. Immunol. Res. 2016: 1958650.
114. Lai, W. K., S. M. Curbishley, S. Goddard, E. Alabraba, J. Shaw, J. Youster, J. McKeating, and D. H. Adams. 2007. Hepatitis C is associated with perturbation of intrahepatic myeloid and plasmacytoid dendritic cell function. J. Hepatol. 47: 338-347.
115. Akbari, O., R. H. DeKruyff, and D. T. Umetsu. 2001. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat. Immunol. 2: 725-731.
116. Kalinski, P., C. M. Hilkens, A. Snijders, F. G. Snijdewint, and M. L. Kapsenberg. 1997. IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells. J. Immunol. 159: 28-35.
117. Selenko-Gebauer, N., O. Majdic, A. Szekeres, G. Höfler, E. Guthann, U. Korthaüer, G. Zlabinger, P. Steinberger, W. F. Pickl, H. Stockinger, et al. 2003. B7-H1 (programmed death-1 ligand) on dendritic cells is involved in the induction and maintenance of T cell anergy. J. Immunol. 170: 3637-3644.
118. Popov, A., J. Driesen, Z. Abdullah, C. Wickenhauser, M. Beyer, S. Debey-Pascher, T. Saric, S. Kummer, O. Takikawa, E. Domann, et al. 2008. Infection of myeloid dendritic cells with Listeria monocytogenes leads to the suppression of T cell function by multiple inhibitory mechanisms. J. Immunol. 181: 4976-4988.
119. Schmidt, S. V., A. C. Nino-Castro, and J. L. Schultze. 2012. Regulatory dendritic cells: there is more than just immune activation. Front. Immunol. 3: 274.
120. Sevilla, N., D. B. McGavern, C. Teng, S. Kunz, and M. B. A. Oldstone. 2004. Viral targeting of hematopoietic progenitors and inhibition of DC maturation as a dual strategy for immune subversion. J. Clin. Invest. 113: 737-745.
121. Trautmann, L., L. Janbazian, N. Chomont, E. A. Said, S. Gimmig, B. Bessette, M. R. Boulassel, E. Delwart, H. Sepulveda, R. S. Balderas, et al. 2006. Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat. Med. 12: 1198-1202.
122. Penna, A., M. Pilli, A. Zerbini, A. Orlandini, S. Mezzadri, L. Sacchelli, G. Missale, and C. Ferrari. 2007. Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection. Hepatology 45: 588-601.
123. Butte, M. J., M. E. Keir, T. B. Phamduy, A. H. Sharpe, and G. J. Freeman. 2007. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. Immunity 27: 111-122.
124. Francisco, L. M., V. H. Salinas, K. E. Brown, V. K. Vanguri, G. J. Freeman, V. K. Kuchroo, and A. H. Sharpe. 2009. PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J. Exp. Med. 206: 3015-3029.
125. Hotta-Iwamura, C., and K. V. Tarbell. 2016. Type 1 diabetes genetic susceptibility and dendritic cell function: potential targets for treatment. J. Leukoc. Biol. 100: 65-80.
126. Amodio, G., and S. Gregori. 2012. Dendritic cells a double-edge sword in autoimmune responses. Front. Immunol. 3: 233.
127. López de Padilla, C. M., and A. M. Reed. 2007. Involvement of dendritic cells in autoimmune diseases in children. Pediatr. Rheumatol. Online J. 5: 16.
128. Santin, I., and D. L. Eizirik. 2013. Candidate genes for type 1 diabetes modulate pancreatic islet inflammation and b-cell apoptosis. Diabetes Obes. Metab. 15(Suppl. 3): 71-81.
129. Ferreira, R. C., H. Guo, R. M. Coulson, D. J. Smyth, M. L. Pekalski, O. S. Burren, A. J. Cutler, J. D. Doecke, S. Flint, E. F. McKinney, et al. 2014. A type I interferon transcriptional signature precedes autoimmunity in children genetically at risk for type 1 diabetes. Diabetes 63: 2538-2550.
130. Obermoser, G., R. D. Sontheimer, and B. Zelger. 2010. Overview of common, rare and atypical manifestations of cutaneous lupus erythematosus and histopathological correlates. Lupus 19: 1050-1070.
131. Palucka, A. K., J. Banchereau, P. Blanco, and V. Pascual. 2002. The interplay of dendritic cell subsets in systemic lupus erythematosus. Immunol. Cell Biol. 80: 484-488.
132. Chaussabel, D., C. Quinn, J. Shen, P. Patel, C. Glaser, N. Baldwin, D. Stichweh, D. Blankenship, L. Li, I. Munagala, et al. 2008. A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. Immunity 29: 150-164.
133. Niewold, T. B. 2014. Type I interferon in human autoimmunity. Front. Immunol. 5: 306.
134. Meyer, O. 2009. Interferons and autoimmune disorders. Joint Bone Spine 76: 464-473.
135. Diana, J., Y. Simoni, L. Furio, L. Beaudoin, B. Agerberth, F. Barrat, and A. Lehuen. 2013. Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes. Nat. Med. 19: 65-73.
136. Li, Q., B. Xu, S. A. Michie, K. H. Rubins, R. D. Schreriber, and H. O. McDevitt. 2008. Interferon-A initiates type 1 diabetes in nonobese diabetic mice. Proc. Natl. Acad. Sci. USA 105: 12439-12444.
137. Carrero, J. A., B. Calderon, F. Towfic, M. N. Artyomov, and E. R. Unanue. 2013. Defining the transcriptional and cellular landscape of type 1 diabetes in the NOD mouse. [Published erratum appears in 2014 PLoS One. DOI: 10.1371/annotation/f277b29e-361b-4e56-b55b-612ebaca0432] PLoS One 8: e59701.
138. Rahman, M. J., G. Rahir, M. B. Dong, Y. Zhao, K. B. Rodrigues, C. Hotta-Iwamura, Y. Chen, A. Guerrero, and K. V. Tarbell. 2016. Despite increased type 1 IFN, autoimmune nonobese diabetic mice display impaired dendritic cell response to CpG and decreased nuclear localization of IFN-activated STAT1. J. Immunol. 196: 2031-2040.
139. Poligone, B., D. J. Weaver, Jr., P. Sen, A. S. Baldwin, Jr., and R. Tisch. 2002. Elevated NF-kB activation in nonobese diabetic mouse dendritic cells results in enhanced APC function. J. Immunol. 168: 188-196.
140. Weaver, D.J., Jr., B. Poligone, T. Bui, U. M. Abdel-Motal, A. S. Baldwin, Jr., and R. Tisch. 2001. Dendritic cells from nonobese diabetic mice exhibit a defect in NF-kB regulation due to a hyperactive IkB kinase. J. Immunol. 167: 1461-1468.
141. Mayer-Barber, K. D., and B. Yan. 2017. Clash of the cytokine titans: counterregulation of interleukin-1 and type I interferon-mediated inflammatory responses. Cell. Mol. Immunol. 14: 22-35.
142. Blanco, P., A. K. Palucka, V. Pascual, and J. Banchereau. 2008. Dendritic cells and cytokines in human inflammatory and autoimmune diseases. Cytokine Growth Factor Rev. 19: 41-52.
143. Ueno, H., E. Klechevsky, R. Morita, C. Aspord, T. Cao, T. Matsui, T. Di Pucchio, J. Connolly, J. W. Fay, V. Pascual, et al. 2007. Dendritic cell subsets in health and disease. Immunol. Rev. 219: 118-142.
144. Chen, Y. G., S. M. Cabrera, S. Jia, M. L. Kaldunski, J. Kramer, S. Cheong, R. Geoffrey, M. F. Roethle, J. E. Woodliff, C. J. Greenbaum, et al. 2014. Molecular signatures differentiate immune states in type 1 diabetic families. Diabetes 63: 3960-3973.
145. Price, J. D., N. M. Beauchamp, G. Rahir, Y. Zhao, C. C. Rieger, A. W. Lau-Kilby, and K. V. Tarbell. 2014. CD8+ dendritic cell-mediated tolerance of autoreactive CD4+ T cells is deficient in NOD mice and can be corrected by blocking CD40L. J. Leukoc. Biol. 95: 325-336.
146. Serra, P., A. Amrani, J. Yamanouchi, B. Han, S. Thiessen, T. Utsugi, J. Verdaguer, and P. Santamaria. 2003. CD40 ligation releases immature dendritic cells from the control of regulatory CD4+CD25+ T cells. Immunity 19: 877-889.
147. Vaitaitis, G. M., M. H. Olmstead, D. M. Waid, J. R. Carter, and D. H. Wagner, Jr. 2014. A CD40-targeted peptide controls and reverses type 1 diabetes in NOD mice. Diabetologia 57: 2366-2373.
148. Mahmoud, T. I., J. Wang, J. L. Karnell, Q. Wang, S. Wang, B. Naiman, P. Gross, P. Z. Brohawn, C. Morehouse, J. Aoyama, et al. 2016. Autoimmune manifestations in aged mice arise from early-life immune dysregulation. Sci. Transl. Med. 8: 361ra137.
149. Lee, C. N., A. M. Lew, K. Shortman, and L. Wu. 2015. NOD mice are functionally deficient in the capacity of cross-presentation. Immunol. Cell Biol. 93: 548-557.
150. Joffre, O. P., E. Segura, A. Savina, and S. Amigorena. 2012. Cross-presentation by dendritic cells. Nat. Rev. Immunol. 12: 557-569.
151. Ferris, S. T., J. A. Carrero, J. F. Mohan, B. Calderon, K. M. Murphy, and E. R. Unanue. 2014. A minor subset of Batf3-dependent antigen-presenting cells in islets of Langerhans is essential for the development of autoimmune diabetes. Immunity 41: 657-669.
152. Pelletier, A. N., and S. Lesage. 2013. The Idd13 congenic interval defines the number of merocytic dendritic cells, a novel trait associated with autoimmune diabetes susceptibility. J. Autoimmun. 43: 70-77.
153. Katz, J. D., J. K. Ondr, R. J. Opoka, Z. Garcia, and E. M. Janssen. 2010. Cutting edge: merocytic dendritic cells break T cell tolerance to b cell antigens in nonobese diabetic mouse diabetes. J. Immunol. 185: 1999-2003.
154. Thacker, R. I., and E. M. Janssen. 2012. Cross-presentation of cell-associated antigens by mouse splenic dendritic cell populations. Front. Immunol. 3: 41.
155. Mohan, J. F., and E. R. Unanue. 2012. Unconventional recognition of peptides by T cells and the implications for autoimmunity. Nat. Rev. Immunol. 12: 721-728.
156. Greter, M., F. L. Heppner, M. P. Lemos, B. M. Odermatt, N. Goebels, T. Laufer, R. J. Noelle, and B. Becher. 2005. Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat. Med. 11: 328-334.
157. Bailey-Bucktrout, S. L., S. C. Caulkins, G. Goings, J. A. A. Fischer, A. Dzionek, and S. D. Miller. 2008. Cutting edge: central nervous system plasmacytoid dendritic cells regulate the severity of relapsing experimental autoimmune encephalomyelitis. J. Immunol. 180: 6457-6461.
158. Ioannou, M., T. Alissafi, L. Boon, D. Boumpas, and P. Verginis. 2013. In vivo ablation of plasmacytoid dendritic cells inhibits autoimmunity through expansion of myeloid-derived suppressor cells. J. Immunol. 190: 2631-2640.
159. Koyama, M., M. Cheong, K. A. Markey, K. H. Gartlan, R. D. Kuns, K. R. Locke, K. E. Lineburg, B. E. Teal, L. Leveque-El Mouttie, M. D. Bunting, et al. 2015. Donor colonic CD103+ dendritic cells determine the severity of acute graft-versushost disease. J. Exp. Med. 212: 1303-1321.
160. Leveque-El Mouttie, L., M. Koyama, L. Le Texier, K. A. Markey, M. Cheong, R. D. Kuns, K. E. Lineburg, B. E. Teal, K. A. Alexander, A. D. Clouston, et al. 2016. Corruption of dendritic cell antigen presentation during acute GVHD leads to regulatory T-cell failure and chronic GVHD. Blood 128: 794-804.
161. Gauthier, S. D., D. Leboeuf, R. Manuguerra-Gagné, L. Gaboury, and M. Guimond. 2015. Stromal-derived factor-1a and interleukin-7 treatment improves homeostatic proliferation of naïve CD4+ T cells after allogeneic stem cell transplantation. Biol. Blood Marrow Transplant. 21: 1721-1731.
162. Ochando, J. C., C. Homma, Y. Yang, A. Hidalgo, A. Garin, F. Tacke, V. Angeli, Y. Li, P. Boros, Y. Ding, et al. 2006. Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nat. Immunol. 7: 652-662.
163. Yun, T. J., J. S. Lee, K. Machmach, D. Shim, J. Choi, Y. J. Wi, H. S. Jang, I. H. Jung, K. Kim, W. K. Yoon, et al. 2016. Indoleamine 2,3-dioxygenaseexpressing aortic plasmacytoid dendritic cells protect against atherosclerosis by induction of regulatory T cells. Cell Metab. 23: 852-866.
164. Jongbloed, S. L., A. J. Kassianos, K. J. McDonald, G. J. Clark, X. Ju, C. E. Angel, C. J. Chen, P. R. Dunbar, R. B. Wadley, V. Jeet, et al. 2010. Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that crosspresents necrotic cell antigens. J. Exp. Med. 207: 1247-1260.
165. Robbins, S. H., T. Walzer, D. Dembélé, C. Thibault, A. Defays, G. Bessou, H. Xu, E. Vivier, M. Sellars, P. Pierre, et al. 2008. Novel insights into the relationships between dendritic cell subsets in human and mouse revealed by genomewide expression profiling. Genome Biol. 9: R17.
166. Guilliams, M., C. A. Dutertre, C. L. Scott, N. McGovern, D. Sichien, S. Chakarov, S. Van Gassen, J. Chen, M. Poidinger, S. De Prijck, et al. 2016. Unsupervised high-dimensional analysis aligns dendritic cells across tissues and species. Immunity 45: 669-684.